The association between leukocyte telomere length and cigarette smoking, dietary and physical variables, and risk of prostate cancer

Aging Cell

Volumn 8, Issue 4, 2009, Pages 405-413

  Mirabello, Lisa ^a   Huang, Wen Yi ^a   Wong, Jason Y Y ^b   Chatterjee, Nilanjan ^a   Reding, Douglas ^c   Crawford, E David ^d   De Vivo, Immaculata ^b   Hayes, Richard B ^a   Savage, Sharon A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MARSHFIELD CLINIC   (United States)

^d UNIVERSITY OF COLORADO   (United States)

Author keywords

Epidemiology; Lifestyle; Prostate cancer; Risk; Telomere

Indexed keywords

ADULT; ADVANCED CANCER; AGE; AGED; ARTICLE; BODY MASS; CANCER RISK; CHROMOSOMAL PARAMETERS; CIGARETTE SMOKING; CONTROLLED STUDY; DIET; DISEASE ASSOCIATION; EXERCISE; HEALTH STATUS; HUMAN; HUMAN CELL; LEUKOCYTE; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PHYSICAL PARAMETERS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; SMOKING CESSATION; TELOMERE; TELOMERE LENGTH;

AGED; CASE-CONTROL STUDIES; DIET; HUMANS; LEUKOCYTES; LIFE STYLE; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RISK FACTORS; SMOKING; TELOMERE;

NICOTIANA TABACUM;

EID: 67651183852     PISSN: 14749718     EISSN: 14749726     Source Type: Journal    
DOI: 10.1111/j.1474-9726.2009.00485.x     Document Type: Article

References (70)

1. Ahn J, Peters U, Albanes D, Purdue MP, Abnet CC, Chatterjee N, Horst RL, Hollis BW, Huang WY, Shikany JM, Hayes RB, Prostate Lung, Colorectal, and Ovarian Cancer Screening Trial Project Team (2008). Serum vitamin D concentration and prostate cancer risk: A nested case-control study. J. Natl Cancer Inst. 100, 796-804.
2. Aikata H, Takaishi H, Kawakami Y, Takahashi S, Kitamoto M, Nakanishi T, Nakamura Y, Shimamoto F, Kajiyama G, Ide T (2000) Telomere reduction in human liver tissues with age and chronic inflammation. Exp. Cell Res. 256, 578-582.
3. Alberg A (2002) The influence of cigarette smoking on circulating concentrations of antioxidant micronutrients. Toxicology 180, 121-137.
4. American Cancer Society, Inc. (2008). Cancer Facts and Figures 2008. Atlanta, GA: American Cancer Society, Inc.
5. Artandi SE, Chang S, Lee SL, Alson S, Gottlieb GJ, Chin L, DePinho RA (2000) Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 406, 641-645.
6. Aubert G, Lansdorp PM (2008) Telomeres and aging. Physiol. Rev. 88, 557-579.
7. Aviv A, Chen W, Gardner JP, Kimura M, Brimacombe M, Cao X, Srinivasan SR, Berenson GS (2009) Leukocyte telomere dynamics: Longitudinal findings among young adults in the Bogalusa Heart Study. Am. J. Epidemiol. 169, 323-329.
8. Balasubramanyam M, Adaikalakoteswari A, Monickaraj SF, Mohan V (2007) Telomere shortening & metabolic/vascular diseases. Indian J. Med. Res. 125, 441-450.
9. Bekaert S, De Meyer T, Rietzschel ER, De Buyzere ML, De Bacquer D, Langlois M, Segers P, Cooman L, Van Damme P, Cassiman P, Van Criekinge W, Verdonck P, De Backer GG, Gillebert TC, Van Oostveldt P, Asklepios investigators (2007) Telomere length and cardiovascular risk factors in a middle-aged population free of overt cardiovascular disease. Aging Cell. 6, 639-647.
10. Bischoff C, Petersen HC, Graakjaer J, Andersen-Ranberg K, Vaupel JW, Bohr VA, Kølvraa S, Christensen K (2006) No association between telomere length and survival among the elderly and oldest old. Epidemiology. 17, 190-194.
11. Blasco MA, Lee HW, Hande MP, Samper E, Lansdorp PM, DePinho RA, Greider CW (1997) Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91, 25-34.
12. Block G, Dietrich M, Norkus EP, Morrow JD, Hudes M, Caan B, Packer L (2002) Factors associated with oxidative stress in human populations. Am. J. Epidemiol. 156, 274-285.
13. Broberg K, Björk J, Paulsson K, Höglund M, Albin M (2005) Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer. Carcinogenesis. 26, 1263-1271.
14. Cawthon RM (2002) Telomere measurement by quantitative PCR. Nucleic Acids Res. 30, e47.
15. Cherkas LF, Aviv A, Valdes AM, Hunkin JL, Gardner JP, Surdulescu GL, Kimura M, Spector TD (2006) The effects of social status on biological aging as measured by white-blood-cell telomere length. Aging Cell. 5, 361-365.
16. Cherkas LF, Hunkin JL, Kato BS, Richards JB, Gardner JP, Surdulescu GL, Kimura M, Lu X, Spector TD, Aviv A (2008) The association between physical activity in leisure time and leukocyte telomere length. Arch. Intern. Med. 168, 154-158.
17. Collins K, Mitchell JR (2002) Telomerase in the human organism. Oncogene 21, 564-579.
18. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420, 860-867.
19. Cox B, Sneyd MJ, Paul C, Skegg DC (2006) Risk factors for prostate cancer: A national case-control study. Int. J. Cancer 119, 1690-1694.
20. Darlington GA, Kreiger N, Lightfoot N, Purdham J, Sass-Kortsak A (2007) Prostate cancer risk and diet, recreational physical activity and cigarette smoking. Chronic Dis Can. 27, 145-153.
21. Donaldson L, Fordyce CA, Gilliland F, Smith A, Feddersen R, Joste N, Moyzis R, Griffith J (1999) Association between outcome and telomere DNA content in prostate cancer. J. Urol. 162, 1788-1792.
22. Eeles RA, Kote-Jarai Z, Giles GG, Olama AAA, Guy M, Jugurnauth SK, Mulholland S, Leongamornlert DA, Edwards SM, Morrison J, Field HI, Southey MC, Severi G, Donovan JL, Hamdy FC, Dearnaley DP, Muir KR, Smith C, Bagnato M, Ardern-Jones AT, Hall AL, O'Brien LT, Gehr-Swain BN, Wilkinson RA, Cox A, Lewis S, Brown PM, Jhavar SG, Tymrakiewicz M, Lophatananon A, Bryant SL, Horwich A, Huddart RA, Khoo VS, Parker CC, Woodhouse CJ, Thompson A, Christmas T, Ogden C, Fisher C, Jamieson C, Cooper CS, English DR, Hopper JL, Neal DE, Easton DF (2008) Multiple newly identified loci associated with prostate cancer susceptibility. Nat. Genet. 40, 316-321.
23. Fordyce CA, Heaphy CM, Joste NE, Smith AY, Hunt WC, Griffith JK (2005) Association between cancer-free survival and telomere DNA content in prostate tumors. J. Urol. 173, 610-614.
24. Gardner JP, Li S, Srinivasan SR, Chen W, Kimura M, Lu X, Berenson GS, Aviv A (2005) Rise in insulin resistance is associated with escalated telomere attrition. Circulation 111, 2171-2177.
25. Gilley D, Tanaka H, Herbert BS (2005). Telomere dysfunction in aging and cancer. Int. J. Biochem. Cell Biol. 37, 1000-1013.
26. Gohagan JK, Prorok PC, Hayes RB, Kramer BS (2000) The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: History, organization, and status. Control. Clin. Trials 21, 251S-272S.
27. Harris SE, Deary IJ, MacIntyre A, Lamb KJ, Radhakrishnan K, Starr JM, Whalley LJ, Shiels PG (2006) The association between telomere length, physical health, cognitive ageing, and mortality in non-demented older people. Neurosci. Lett. 406, 260-264.
28. Houben JM, Moonen HJ, van Schooten FJ, Hageman GJ (2008) Telomere length assessment: Biomarker of chronic oxidative stress? Free Radic. Biol. Med. 44, 235-246.
29. Jang J, Choi Y, Lee W, Choi J, Cha S, Kim Y, Kim C, Kam S, Jung T, Park J (2008) Telomere length and the risk of lung cancer. Cancer Sci. 99, 1385-1389.
30. Jeanclos E, Krolewski A, Skurnick J, Kimura M, Aviv H, Warram JH, Aviv A (1998) Shortened telomere length in white blood cells of patients with IDDM. Diabetes 47, 482-486.
31. Joshua AM, Vukovic B, Braudey I, Husseinb S, Zielenska M, Srigleyb J, Evans A, Squire JA (2007) Telomere attrition in isolated high-grade prostaticintraepithelial neoplasia and surrounding stroma is predictive of prostate cancer. Neoplasia. 9, 81-89.
32. Keaney Jr JF, Larson MG, Vasan RS, Wilson PWF, Lipinska I, Corey D, Massaro JM, Sutherland P, Vita JA, Benjamin EJ (2003) Obesity and systemic oxidative stress: Clinical correlates of oxidative stress in the Framingham Study. Arterioscler. Thromb. Vasc. Biol. 23, 434-439.
33. Kristal AR, Arnold KB, Schenk JM, Neuhouser ML, Weiss N, Goodman P, Antvelink CM, Penson DF, Thompson IM (2007) Race/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: Results from the prostate cancer prevention trial. J. Urol. 177, 1395-1400.
34. Kundu JK, Surh YJ (2008) Inflammation: Gearing the journey to cancer. Mutat. Res. 659, 15-30.
35. deLange T (2005) Shelterin: The protein complex that shapes and safeguards human telomeres. Genes Dev. 19, 2100-2110.
36. Lung FW, Ku CS, Kao WT (2008) Telomere length may be associated with hypertension. J. Hum. Hypertens. 22, 230-232.
37. Maser RS, DePinho RA (2002) Connecting Chromosomes, Crisis, and Cancer. Science 297, 565-569.
38. Mayer S, Brüderlein S, Perner S, Waibel I, Holdenried A, Ciloglu N, Hasel C, Mattfeldt T, Nielsen K, Möller P (2006) Sex-specific telomere length profiles and age-dependent erosion dynamics of individual chromosome arms in humans. Cytogenet. Genome. Res. 112, 194-201.
39. McGrath M, Wong JYY, Michaud D, Hunter DJ, De Vivo I (2007) Telomere length, cigarette smoking, and bladder cancer risk in men and women. Cancer Epidemiol. Biomarkers Prev. 16, 815-819.
40. Meeker A, Hicks J, Platz E, March G, Bennett C, Delannoy M, De Marzo A (2002) Telomere shortening is an early somatic DNA alteration in human prostate tumorigenesis. Cancer Res. 62, 6405-6409.
41. Moon I K, Jarstfer M B (2007) The human telomere and its relationship to human disease, therapy, and tissue engineering. Front. Biosci. 12, 4595-4620.
42. Morlá M, Busquets X, Pons J, Sauleda J, MacNee W, Agustí AG (2006) Telomere shortening in smokers with and without COPD. Eur. Respir. J. 27, 525-528.
43. Nawrot TS, Staessen JA, Gardner JP, Aviv A (2004) Telomere length and possible link to X chromosome. Lancet 363, 507-510.
44. O'Donnell C, Demissie S, Kimura M, Levy D, Gardner J, White C, D'Agostino R, Wolf P, Polak J, Cupples L, Aviv A (2008) Leukocyte Telomere Length and Carotid Artery Intimal Medial Thickness. The Framingham Heart Study. Arterioscler Thromb Vasc Biol. 28, 1165-1171.
45. Ornish D, Lin J, Daubenmier J, Weidner G, Epel E, Kemp C, Magbanua MJ, Marlin R, Yglecias L, Carroll PR, Blackburn EH (2008) Increased telomerase activity and comprehensive lifestyle changes: A pilot study. Lancet Oncol. 9, 1048-1057.
46. Prorok PC, Andriole GL, Bresalier RS, Buys SS, Chia D, Crawford ED, Fogel R, Gelmann EP, Gilbert F, Hasson MA, Hayes RB, Johnson CC, Mandel JS, Oberman A, O'Brien B, Oken MM, Rafla S, Reding D, Rutt W, Weissfeld JL, Yokochi L, Gohagan JK, Prostate Lung, Colorectal and Ovarian Cancer Screening Trial Project Team. (2000). Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control. Clin. Trials. 21, 273S-309S.
47. Richards JB, Valdes AM, Gardner JP, Paximadas D, Kimura M, Nessa A, Lu X, Surdulescu GL, Swaminathan R, Spector TD, Aviv A (2007) Higher serum vitamin D concentrations are associated with longer leukocyte telomere length in woman. Am. J. Clin. Nutr. 86, 1420-1425.
48. Risques RA, Vaughan TL, Li X, Odze RD, Blount PL, Ayub K, Gallaher JL, Reid BJ, Rabinovitch PS (2007) Leukocyte telomere length predicts cancer risk in Barrett's esophagus. Cancer Epidemiol. Biomarkers Prev. 16, 2649-2655.
49. Rudolph KL, Chang S, Lee HW, Blasco M, Gottlieb GJ, Greider C, DePinho RA (1999) Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 96, 701-712.
50. Sampson MJ, Winterbone MS, Hughes JC, Dozio N, Hughes DA (2006) Monocyte telomere shortening and oxidative DNA damage in type 2 diabetes. Diabetes Care. 29, 283-289.
51. Schaid DJ (2004) The complex genetic epidemiology of prostate cancer. Hum. Mol. Genet. 13, R103-121.
52. Serrano AL, Andres V (2004) Telomeres and cardiovascular disease: Does size matter? Circ. Res. 94, 575-584.
53. Shao L, Wood CG, Zhang D, Tannir NM, Matin S, Dinney CP, Wu X (2007) Telomere dysfunction in peripheral lymphocytes as a potential predisposition factor for renal cancer. J. Urol. 178, 1492-1496.
54. Shay JW, Bacchetti S (1997) A survey of telomerase activity in human cancer. Eur. J. Cancer 33, 787-791.
55. Shay JW, Roninson IB (2004) Hallmarks of senescence in carcinogenesis and cancer therapy. Oncogene 23, 2919-2933.
56. Shen J, Terry MB, Gurvich I, Liao Y, Senie RT, Santella RM (2007) Short telomere length and breast cancer risk: A study in sister sets. Cancer Res. 67, 5538-5544.
57. Sutcliffe S, Platz EA (2008) Inflammation and prostate cancer: A focus on infections. Curr Urol Rep. 9, 243-249.
58. Svenson U, Nordfjäll K, Stegmayr B, Manjer J, Nilsson P, Tavelin B, Henriksson R, Lenner P, Roos G (2008) Breast cancer survival is associated with telomere length in peripheral blood cells. Cancer Res. 68, 3618-3623.
59. Tchirkov A, Lansdorp PM (2003) Role of oxidative stress in telomere shortening in cultured fibroblasts from normal individuals and patients with ataxia-telangiectasia. Hum. Mol. Genet. 12, 227-232.
60. Thomas G, Jacobs KB, Yeager M, Kraft P, Wacholder S, Orr N, Yu K, Chatterjee N, Welch R, Hutchinson A, Crenshaw A, Cancel-Tassin G, Staats BJ, Wang Z, Gonzalez-Bosquet J, Fang J, Deng X, Berndt SI, Calle EE, Feigelson HS, Thun MJ, Rodriguez C, Albanes D, Virtamo J, Weinstein S, Schumacher FR, Giovannucci E, Willett WC, Cussenot O, Valeri A, Andriole GL, Crawford ED, Tucker M, Gerhard DS, Fraumeni JF, Hoover R, Hayes RB, Hunter DJ, Chanock SJ (2008) Multiple loci identified in a genome-wide association study of prostate cancer. Nat. Genet. 40, 310-315.
61. US Department of Health and Human Services (2004). The Health Consequences of Smoking: A Report of the Surgeon Generaled eds). Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health.
62. Valdes AM, Andrew T, Gardner JP, Kimura M, Oelsner E, Cherkas LF, Aviv A, Spector TD (2005) Obesity, cigarette smoking, and telomere length in women. Lancet 366, 662-664.
63. Vasan RS, Demissie S, Kimura M, Cupples LA, Rifai N, White C, Wang TJ, Gardner JP, Cao X, Benjamin EJ, Levy D, Aviv A (2008) Association of leukocyte telomere length with circulating biomarkers of the renin-angiotensin-aldosterone system. The Framingham Heart Study. Circulation 117, 1138-1144.
64. Vasto S, Carruba G, Candore G, Italiano E, Di Bona D, Caruso C (2008) Inflammation and prostate cancer. Future Oncol. 4, 637-645.
65. Wang H, Chen H, Gao X, McGrath M, Deer D, Immaculata DV, Schwarzschild MA, Ascherio A (2008) Telomere length and risk of Parkinson's disease. Mov. Disord. 23, 302-305.
66. Wong JM, Collins K (2003) Telomere maintenance and disease. Lancet 362, 983-988.
67. Wu X, Amos CI, Zhu Y, Zhao H, Grossman BH, Shay JW, Luo S, Hong WK, Spitz MR (2003) Telomere dysfunction: A potential cancer predisposition factor. J. Natl Cancer Inst. 95, 1211-1218.
68. Yeager M, Orr N, Hayes RB, Jacobs KB, Kraft P, Wacholder S, Minichiello MJ, Fearnhead P, Yu K, Chatterjee N, Wang Z, Welch R, Staats BJ, Calle EE, Feigelson HS, Thun MJ., Rodriguez C, Albanes D, Virtamo J, Weinstein S, Schumacher FR, Giovannucci E, Willett WC, Cancel-Tassin G, Cussenot O, Valeri A, Andriole GL, Gelmann EP, Tucker M, Gerhard DS, Fraumeni JF, Hoover R, Hunter DJ, Chanock SJ, Thomas G (2007) Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat. Genet. 39, 645-649.
69. Zannolli R, Mohn A, Buoni S, Pietrobelli A, Messina M, Chiarelli F, Miracco C (2008) Telomere length and obesity. Acta Paediatr. 97, 952-954.
70. von Zglinicki T (2002) Oxidative stress shortens telomeres. Trends Biochem. Sci. 27, 339-344.